Lavipharm
 |
 | |
Company type | S.A. |
|---|---|
| ATHEX was Lavi | |
| Founded | 1911 |
| Headquarters | Athens, Greece |
Key people | Telemaque Lavidas (CEO) |
| Products | pharmaceutical, cosmetic, veterinary & Consumer health products |
| Revenue | €61,001,000 (2024) |
| €25,080,000 (2024) | |
| Footnotes / references [1] | |
Lavipharm S.A. is the largest integrated Greek pharmaceutical company that develops, manufactures, markets and distributes pharmaceutical, cosmetic, veterinary and consumer health products in Greece and internationally (France, Cyprus and the United States). It was founded in 1911, by the Lavidas’ family, and listed on the Athens Stock Exchange in 1995.[2]
References
[edit]- ^ "Flash Note: Annual Financial Results 2024" (PDF). Lavipharm.
- ^ "Lavipharm | Our History". Retrieved 2026-03-25.
External links
[edit]
| Economy of Greece |
|---|
 |
| Overview |
| History |
| Related |
 | This article on a Greek company is a stub. You can help Wikipedia by adding missing information. |